Loading…
CIK 0001616824 • 6 13F filings • May 7, 2025 – Aug 7, 2026
Import this data to Google Sheets with:
=jivedata("bml-capital-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC | COM | $21.8M | 17.6% | 14,250,000 SH | |
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | $12.0M | 9.7% | 2,742,317 SH | |
| ALUMIS INC | COM | $305K | 0.2% | 49,627 SH | |
| AN2 THERAPEUTICS INC | COM | $7.8M | 6.3% | 5,749,432 SH | |
| ASTROTECH CORP | COM | $1.4M | 1.2% | 220,410 SH | |
| ATEA PHARMACEUTICALS INC | COM | $22.8M | 18.4% | 7,609,812 SH | |
| ATHIRA PHARMA INC | COM | $912K | 0.7% | 3,200,667 SH | |
| CONNECT BIOPHARMA HLDGS LTD | ADS | $1.2M | 0.9% | 2,093,232 SH | |
| ELEVATION ONCOLOGY INC | COM | $1.5M | 1.2% | 5,890,934 SH | |
| ESSA PHARMA INC | COM NEW | $6.7M | 5.4% | 4,221,546 SH | |
| HILLEVAX INC | COM | $30K | 0.0% | 20,760 SH | |
| IKENA ONCOLOGY INC | COM | $4.7M | 3.8% | 3,710,803 SH | |
| INSTIL BIO INC | COM NEW | $7.2M | 5.9% | 416,720 SH | |
| KEZAR LIFE SCIENCES INC | COM NEW | $2.0M | 1.6% | 408,138 SH | |
| LAVA THERAPEUTICS NV | SHS | $2.5M | 2.0% | 1,960,610 SH | |
| LISATA THERAPEUTICS INC | COM | $510K | 0.4% | 216,853 SH | |
| MILESTONE PHARMACEUTICALS IN | COM | $909K | 0.7% | 1,136,091 SH | |
| NEXTCURE INC | COM | $131K | 0.1% | 273,536 SH | |
| ORAMED PHARMACEUTICALS INC | COM NEW | $6.5M | 5.2% | 3,020,748 SH | |
| PMV PHARMACEUTICALS INC | COM | $4.1M | 3.3% | 3,747,612 SH | |
| SAGE THERAPEUTICS INC | COM | $1.1M | 0.9% | 135,095 SH | |
| THIRD HARMONIC BIO INC | COM | $13.3M | 10.7% | 3,824,417 SH | |
| TURNSTONE BIOLOGICS CORP | COM | $452K | 0.4% | 1,103,386 SH | |
| VERRICA PHARMACEUTICALS INC | COM | $77K | 0.1% | 174,651 SH | |
| VISTAGEN THERAPEUTICS INC | COM | $375K | 0.3% | 150,000 SH | |
| WHITEHAWK THERAPEUTICS INC | COM | $3.4M | 2.7% | 1,890,245 SH |
| 13F-HR |
| 0001754960-26-000696 |
| $176.1M |
| View |
| Aug 11, 2025 | Q2 2025 | 13F-HR | 0001754960-25-000555 | $132.2M | View |
| May 6, 2026 | Q1 2026 | 13F-HR | 0001754960-26-000359 | $155.8M | View |
| May 7, 2025 | Q1 2025 | 13F-HR | 0001754960-25-000280 | $123.6M | View |